See more : Sobute New Materials Co., Ltd (603916.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Denis Chem Lab Limited (DENISCHEM.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Denis Chem Lab Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- U.S. Aerospace, Inc. (USAE) Income Statement Analysis – Financial Results
- Pilani Investment and Industries Corporation Limited (PILANIINVS.NS) Income Statement Analysis – Financial Results
- Delta Electronics (Thailand) Public Company Limited (DELTA.BK) Income Statement Analysis – Financial Results
- Abitare In S.p.A. (ABT.MI) Income Statement Analysis – Financial Results
- Diana Shipping Inc. (DSX) Income Statement Analysis – Financial Results
Denis Chem Lab Limited (DENISCHEM.BO)
About Denis Chem Lab Limited
Denis Chem Lab Ltd. engages in the manufacture and sale of transfusion solution in bottles. It products include antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti anaerobic injections, and irrigation solutions. The company was founded on July 15, 1980 and is headquartered in Jaipur, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.68B | 1.61B | 1.36B | 1.09B | 1.36B | 1.24B | 1.07B | 1.12B | 996.42M | 768.53M | 673.14M | 560.30M |
| Cost of Revenue | 1.08B | 866.05M | 742.23M | 572.97M | 645.63M | 625.25M | 504.47M | 545.56M | 527.13M | 369.27M | 429.26M | 306.48M |
| Gross Profit | 596.25M | 742.00M | 622.69M | 518.46M | 714.06M | 615.91M | 567.73M | 579.10M | 469.30M | 399.26M | 243.87M | 253.82M |
| Gross Profit Ratio | 35.53% | 46.14% | 45.62% | 47.50% | 52.52% | 49.62% | 52.95% | 51.49% | 47.10% | 51.95% | 36.23% | 45.30% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 13.61M | 11.25M | 12.97M | 12.82M | 10.81M | 23.15M | 12.40M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 138.66M | 127.95M | 108.59M | 179.20M | 146.70M | 178.42M | 178.24M | 182.79M | 144.66M | 118.78M | 93.13M |
| SG&A | 0.00 | 152.27M | 139.20M | 121.56M | 192.02M | 157.51M | 201.57M | 190.64M | 182.79M | 144.66M | 118.78M | 93.13M |
| Other Expenses | 453.37M | 5.92M | 10.46M | 3.46M | 2.83M | 197.31K | 625.29K | 773.94K | 710.79K | 619.64K | 227.00K | 0.00 |
| Operating Expenses | 453.37M | 610.65M | 506.05M | 441.96M | 624.25M | 532.06M | 503.27M | 505.85M | 440.64M | 344.86M | 194.62M | 208.53M |
| Cost & Expenses | 1.53B | 1.48B | 1.25B | 1.01B | 1.27B | 1.16B | 1.01B | 1.05B | 967.76M | 714.14M | 623.88M | 515.01M |
| Interest Income | 0.00 | 4.66M | 1.92M | 1.81M | 2.16M | 3.81M | 4.02M | 2.60M | 2.30M | 2.21M | 1.73M | 854.37K |
| Interest Expense | 5.43M | 3.02M | 5.00M | 12.01M | 24.34M | 28.99M | 42.11M | 51.67M | 59.48M | 48.56M | 26.06M | 21.25M |
| Depreciation & Amortization | 69.46M | 78.15M | 57.58M | 59.59M | 66.64M | 63.57M | 59.28M | 67.71M | 56.36M | 38.79M | 13.16M | 12.95M |
| EBITDA | 226.21M | 193.72M | 153.97M | 105.99M | 152.83M | 155.31M | 121.79M | 145.40M | 81.67M | 96.01M | 60.53M | 58.23M |
| EBITDA Ratio | 13.48% | 13.12% | 12.71% | 12.29% | 11.34% | 11.41% | 11.42% | 12.41% | 8.11% | 11.83% | 8.99% | 10.35% |
| Operating Income | 142.88M | 110.90M | 93.96M | 45.92M | 82.78M | 78.27M | 63.15M | 19.88M | -34.17M | 3.59M | 21.31M | 25.39M |
| Operating Income Ratio | 8.51% | 6.90% | 6.88% | 4.21% | 6.09% | 6.31% | 5.89% | 1.77% | -3.43% | 0.47% | 3.17% | 4.53% |
| Total Other Income/Expenses | 8.45M | -1.75M | -5.12M | -15.04M | -32.54M | -24.63M | -44.06M | -51.54M | -62.62M | -50.81M | 0.00 | 0.00 |
| Income Before Tax | 151.32M | 109.16M | 88.84M | 30.87M | 57.27M | 59.22M | 20.40M | 19.68M | -34.17M | 3.59M | 21.31M | 25.39M |
| Income Before Tax Ratio | 9.02% | 6.79% | 6.51% | 2.83% | 4.21% | 4.77% | 1.90% | 1.75% | -3.43% | 0.47% | 3.17% | 4.53% |
| Income Tax Expense | 39.76M | 30.56M | 26.20M | 8.23M | 15.13M | -4.28M | -1.04M | 7.30M | 10.31M | 2.77M | 8.83M | 8.55M |
| Net Income | 111.56M | 78.60M | 62.63M | 22.65M | 42.14M | 63.50M | 21.44M | 12.38M | -44.48M | 816.03K | 12.48M | 16.84M |
| Net Income Ratio | 6.65% | 4.89% | 4.59% | 2.07% | 3.10% | 5.12% | 2.00% | 1.10% | -4.46% | 0.11% | 1.85% | 3.01% |
| EPS | 8.04 | 5.66 | 4.51 | 1.63 | 3.04 | 4.58 | 1.69 | 1.07 | -4.66 | 0.51 | 3.92 | 10.58 |
| EPS Diluted | 8.04 | 5.66 | 4.51 | 1.63 | 3.04 | 4.58 | 1.69 | 1.07 | -4.66 | 0.51 | 3.92 | 10.58 |
| Weighted Avg Shares Out | 13.88M | 13.88M | 13.88M | 13.88M | 13.88M | 13.88M | 12.65M | 11.74M | 9.54M | 9.55M | 3.18M | 1.59M |
| Weighted Avg Shares Out (Dil) | 13.88M | 13.88M | 13.88M | 13.88M | 13.88M | 13.88M | 12.65M | 11.74M | 9.54M | 9.55M | 3.18M | 1.59M |
Source: https://incomestatements.info
Category: Stock Reports